Taxpayers and Seniors Would Lose Billions Under Big Pharma’s EPIC Act
Six of the 8 small molecule drugs currently undergoing Medicare price negotiation would have been excluded under drug industry-backed legislation, a new Public Citizen report finds.The Big Pharma-backed EPIC Act would give drug companies more years of monopoly pricing, gutting the historic 2022 law that for the first time everContinue Reading












